Notice NOT-TR-18-018 from the NIH Guide for Grants and Contracts

Notice NOT-AR-18-016 from the NIH Guide for Grants and Contracts

Notice NOT-AR-18-015 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Software Developer - Bioinformatics Fixed Term Contract - Sept 2019 Cambridge This is a great opportunity for a strong Python or Perl developer to join a world-leading bioinformatics/ genomics organisation based in Cambridge. You will be responsible for Cambridge, England

Negotiable: Paramount Recruitment: Software Developer - Python, Perl Genomics, Bioinformatics, Fixed-term, Cambridgeshire! A fantastic new position has become available for a Software Developer to join a world-leading Genomics company in Cambridgeshire at Senior level. Cambridgeshire, England

Negotiable: Paramount Recruitment: Bioinformatics Postdoc Researcher - Contract Drug Discovery, Pharmaceutical, Greater London! A fantastic new opportunity has become available for a Postdoc Bioinformatician to join a fast-moving biopharmaceutical company as part of their Translationa Berkshire, England

Funding Opportunity PAR-18-646 from the NIH Guide for Grants and Contracts. The goal of this program is to support collaborative translational research projects aligned with NIH efforts to enhance the translation of basic biological discoveries into clinical applications that improve health. It encourages high quality science demonstrating the potential to result in understanding an important disease process or lead to new therapeutic interventions, diagnostics, or prevention strategies within the research interests and priorities of the participating NIH Institutes/Centers (ICs).

Notice NOT-HL-18-594 from the NIH Guide for Grants and Contracts

Notice NOT-HL-18-593 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DK-17-511 from the NIH Guide for Grants and Contracts. This Limited Competition Funding Opportunity Announcement (FOA) invites applications from the Program Directors/Principal Investigators of the six current Clinical Centers (CCs) for The Environmental Determinants of Diabetes in the Young (TEDDY) study, an ongoing epidemiological study of Type 1 Diabetes (T1D) etiology. The TEDDY study involves the rigorous investigation of TEDDY subjects, collecting data and samples, for the identification of infectious agents, dietary factors, or other environmental factors associated with onset of T1D and/or T1D associated autoimmune markers. The six current CCs have been involved in study design and data and biosample acquisition since the inception of the TEDDY consortium. The CCs have recruited participants and followed the subjects over the past 15 years. In addition, the CCs have established effective and proficient collaborations with other components of TEDDY to carry out the studies to meet the objectives of this program. This FOA will support the CCs to allow them to continue to retain, follow clinically, and collect biosamples and data from TEDDY subjects.

Notice NOT-OD-18-139 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MD-18-006 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support time-sensitive research on risk and resilience factors related to short- and long-term health outcomes following Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands. In order for research projects to address risk and resilience in the immediate aftermath and/or recovery period after the recent hurricanes, this initiative will use a shortened submission timeline with expedited peer review, council concurrence and award issuance. The entire cycle, from submission to award, is expected to be within 3-4 months.

Funding Opportunity RFA-AI-18-001 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit grant applications that propose to establish Consortia for HIV/AIDS Vaccine Development (CHAVD) to support a coordinated, multidisciplinary team(s) of researchers focused on iterative approaches to accelerate HIV vaccine development by addressing key immunogen design roadblocks to the discovery and development of a safe and effective antibody-mediated preventive HIV vaccine.

Funding Opportunity PAR-18-639 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that seek to apply one or more innovative methodologies in communication research across the cancer control continuum, from prevention, early detection, diagnosis, treatment, and survivorship, to end of life. Applications to this FOA should utilize one or more of the following analytic approaches, methods, and data sources, including but not limited to social media data mining, Natural Language Processing (NLP) techniques, online social network analysis, crowdsourcing research tools (e.g., mTurk), online search data, Ecological Momentary Assessment, neuroscience and biobehavioral approaches to communication, and geographic information systems. Studies should assess outcomes related to cancer prevention and control (e.g., knowledge, attitudes, beliefs, perceived risk, decision making in screening and treatment, information inequalities, social support, shared decision making, persuasion, caregiving, behavioral intentions, preventive behaviors, and policy support, among others). This FOA utilizes the Exploratory/Developmental Grant (R21) mechanism, which supports investigation of novel scientific ideas or new model systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research. An R21 grant application need not have extensive background material or preliminary information.

Funding Opportunity PAR-18-638 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that seek to apply one or more innovative methodologies in communication research across the cancer control continuum, from prevention, early detection, diagnosis, treatment, and survivorship, to end of life. Applications to this FOA should utilize one or more of the following analytic approaches, methods, and data sources, including but not limited to social media data mining, Natural Language Processing (NLP) techniques, online social network analysis, crowdsourcing research tools (e.g., mTurk), online search data, Ecological Momentary Assessment, neuroscience and biobehavioral approaches to communication, and geographic information systems. Studies should assess outcomes related to cancer prevention and control (e.g., knowledge, attitudes, beliefs, perceived risk, decision making in screening and treatment, information inequalities, social support, shared decision making, persuasion, caregiving, behavioral intentions, preventive behaviors, and policy support, among others). This FOA utilizes the Exploratory/Developmental Grant (R21) mechanism, which supports investigation of novel scientific ideas or new model systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research. An R21 grant application need not have extensive background material or preliminary information.

Notice NOT-EB-18-005 from the NIH Guide for Grants and Contracts

Notice NOT-AT-18-005 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: *Contribute to in-house pipeline to analyse WGS data of patients and aid in the interpretation of findings using clinical bioinformatics capabilities *Perform quality assurance of the analysis and interpretation made by third parties and by our in-house London, England

Notice NOT-HS-18-004 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-18-642 from the NIH Guide for Grants and Contracts. The purpose of the NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training is to support advanced research opportunities for exceptional individuals holding the MD/PhD degree who are early in their research careers and thereby help these individuals transition efficiently and effectively from the period of clinical training to the next stage of their research careers. This administrative supplement program will provide focused, protected research time for eligible individuals during residency and/or clinical fellowship. The proposed research experience must have the potential to contribute significantly to the candidates research career. Administrative supplements must support work within the scope of the original project. All applicants are encouraged to discuss potential requests with the NIMH prior to submission (see Section VII. Agency Contacts).